Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines [1].
Molecular Weight:
890.1
CAS Number:
[2383086-06-2]
Formula:
C49H59N7O7S
* VAT and and shipping costs not included. Errors and price changes excepted